and Ureaplasma spp., in patients with PCOS of reproductive age in 2019–2023 with the assessment of proinflammatory cytokines such as interleukin-1β (Il-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). This evidence concerns the gene IL6 and polycystic ovary syndrome.